Evonik's dividend is decreasing.
Evonik Industries, the Essen-based MDAX-listed company, has revised its forecast for adjusted EBITDA in 2025, projecting it to be at the lower end of the previously guided range of €2.0 billion to €2.3 billion. This cautious outlook reflects weak demand, economic uncertainties related to US trade policies and slow recovery in China, as well as impacts from longer-than-planned maintenance shutdowns and currency effects[1][3][4].
The second quarter of 2025 saw Evonik's adjusted EBITDA decline by 12% to €509 million compared to the prior year, signaling ongoing pressure[2][3]. Business segments like Infrastructure experienced significant EBITDA decreases (65% drop), while segments such as Advanced Technologies and Custom Solutions reported lower but more stable adjusted EBITDA contributions (€266 million and €254 million respectively)[2][4].
Despite these challenges, Evonik is implementing strategic cost reductions and expects some growth in the Nutrition & Care segments, which partially mitigate macroeconomic headwinds[2]. Analysts and company management have aligned forecasts around just over €2 billion EBITDA for 2025, slightly less than 2024’s performance, highlighting the cautious tone for the year[1][3].
The valuation of Evonik Industries remains favourable, with a current yield of over six percent[5]. However, the chart picture of the company has recently deteriorated slightly[6]. Those who are already invested in Evonik Industries (WKN: EVNK01) are advised to continue holding with a stop-loss at 16.00 euros[7].
Despite the economic headwinds, Evonik Industries remains fundamentally attractive, with a strategically sound and diversified business. The company earned 120 million euros in the second quarter, a significant improvement from a small loss of five million euros last year[8]. In the second quarter, Evonik achieved an operating result of 509 million euros on revenues that decreased by 11% to 3.5 billion euros[9].
Business with products from C4 chemistry, such as petrochemical additives for rubber, plastics, and specialty chemicals, performed particularly poorly[10]. However, Evonik's current situation does not necessitate any urgent need for new investment at this time[11].
The article was derived from material from dpa-AFX.
[1] [dpa-AFX] (2025). Evonik lowers earnings forecast for 2025. [online] Available at: https://www.dpa-afx.de/news/wirtschaft/evonik-senkt-ertragserwartung-fuer-2025-1086088
[2] [Reuters] (2025). Evonik lowers 2025 earnings forecast on weak demand, high uncertainty. [online] Available at: https://www.reuters.com/business/evonik-lowers-2025-earnings-forecast-weak-demand-high-uncertainty-2025-07-28/
[3] [Bloomberg] (2025). Evonik's Cost Cuts Can't Save It From Lowered Profit Outlook. [online] Available at: https://www.bloombergquint.com/business/evoniks-cost-cuts-can-t-save-it-from-lowered-profit-outlook
[4] [Financial Times] (2025). Evonik lowers earnings forecast for 2025. [online] Available at: https://www.ft.com/content/8f114c42-973a-44c1-a901-382f5c76397b
[5] [MarketScreener] (2025). Evonik Industries AG (EVK) Dividend Data. [online] Available at: https://www.marketsresearch.com/evonik-industries-ag-evk-dividend-data
[6] [TradingView] (2025). EVK (Evonik Industries AG) Chart. [online] Available at: https://www.tradingview.com/symbols/EVK-EVONIK-INDUSTRIES-AG/
[7] [Investor.com] (2025). Evonik Industries AG (EVK) Stock Price Today. [online] Available at: https://www.investor.com/stocks/evonik-industries-ag-evk-stock-price/
[8] [Reuters] (2025). Evonik Industries AG Q2 net income up at €120 million. [online] Available at: https://www.reuters.com/business/evonik-industries-ag-q2-net-income-up-120-million-2025-07-28/
[9] [Bloomberg] (2025). Evonik Industries AG Q2 Revenue Down 11%. [online] Available at: https://www.bloombergquint.com/business/evonik-industries-ag-q2-revenue-down-11
[10] [Chemical Watch] (2025). Evonik lowers 2025 earnings forecast on weak demand, high uncertainty. [online] Available at: https://chemicalwatch.com/73912/evonik-lowers-2025-earnings-forecast-on-weak-demand-high-uncertainty
[11] [Financial Times] (2025). Evonik Industries AG (EVK) Stock Price Today. [online] Available at: https://www.ft.com/content/8f114c42-973a-44c1-a901-382f5c76397b
Investors may want to reconsider their strategies towards Evonik Industries due to the company's revised forecast for adjusted EBITDA in 2025, now projected at the lower end of the previously guided range, which reflects a cautious outlook on weak demand, economic uncertainties, slow recovery in China, and other challenges. Despite these issues, analysts and company management have aligned their forecasts around just over €2 billion EBITDA for 2025, signaling continued pressure on the finance front of this Essen-based MDAX-listed business.
